NC
ADPT

Northpointe Capital’s Adeptus Health Inc ADPT Stock Holding History

Northpointe Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-339,189
Closed -$14.6M – 217
2016
Q3 		$14.6M Buy
+339,189
New +$15.3M 1.51% 13

Other funds holding ADPT

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Axon Capital New York $69.3M AUM
SFM
Sterling Fund Management Chicago, Illinois $1.82M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Northpointe Capital's ADPT Position: Q4 2016 in Review

Northpointe Capital sold out of Adeptus Health Inc (ADPT) in Q4 2016, closing a stake of 339,189 shares — an estimated $14.6M sold.

Northpointe Capital first reported a position in ADPT in Q3 2016 and held it in 1 quarter. The position peaked at $14.6M in Q3 2016. 106 funds tracked by Wall St. Rank hold ADPT as of Q4 2016.

  • Northpointe Capital reported no remaining Adeptus Health Inc position as of Q4 2016 after selling out during the quarter.
  • Northpointe Capital sold 339,189 Adeptus Health Inc shares in Q4 2016, an estimated $14.6M.
  • Northpointe Capital first reported a position in Adeptus Health Inc in Q3 2016 and held it in 1 quarter.
  • Northpointe Capital's Adeptus Health Inc position peaked at $14.6M in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q4 2016.

Based on Northpointe Capital's 13F filing for Q4 2016, filed 25 Jan 2017.